Thermo Fisher Scientific (China): difference between revisions
Diff·revision 32 → 33·18:00, 26 Jul 2026
Difference between revision 32 and revision 33 of Thermo Fisher Scientific (China). 2 lines changed; the page grew by 2 bytes.
| Revision 32 — 18:00, 26 Jul 2026 Chromatokid (talk) convert the product range to a table so the documentation column lines up 18,573 bytes ±0 | Revision 33 — 18:00, 26 Jul 2026 CheckSumChase (talk) add the minimum order quantity for custom synthesis 18,575 bytes +2 | ||
|---|---|---|---|
| 72 | The PeptidePedia tally records 738 self-reported submissions concerning TFS to August 2026. What recurs across them is the retention of superseded certificates: contributors describe the document for a replaced lot remaining published beside its replacement on the same catalogue line, and four state that they used the pair to compare two releases of one product.{{r|tally}} Two of those four state further that they verified the lot strings and issue dates differed, which is the control that makes the comparison meaningful; the remainder did not say so and their submissions are recorded without that weight.{{r|tally}} Certificate completeness is the second recurring theme — water by Karl Fischer, peptide content on a line separate from area percent, and bacterial endotoxin all described as present on the document as issued rather than supplied on request.{{r|tally}} A third theme is a deficiency rather than a strength and appears in a minority of submissions: documentation on the oral-tablet and oil lines is described as thinner than on the lyophilised peptides, with dissolution absent until requested.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} | 72 | The PeptidePedia tally records 738 self-reported submissions concerning TFS to August 2026. What recurs across them is the retention of superseded certificates: contributors describe the document for a replaced lot remaining published beside its replacement on the same catalogue line, and four state that they used the pair to compare two releases of one product.{{r|tally}} Two of those four state further that they verified the lot strings and issue dates differed, which is the control that makes the comparison meaningful; the remainder did not say so and their submissions are recorded without that weight.{{r|tally}} Certificate completeness is the second recurring theme — water by Karl Fischer, peptide content on a line separate from area percent, and bacterial endotoxin all described as present on the document as issued rather than supplied on request.{{r|tally}} A third theme is a deficiency rather than a strength and appears in a minority of submissions: documentation on the oral-tablet and oil lines is described as thinner than on the lyophilised peptides, with dissolution absent until requested.{{r|tally}} Self-selected; reception rather than quality.{{r|tally}} |
| 73 | 73 | ||
| + | 74 | ||
| + | 75 | ||
| 74 | === How this tally should be read === | 76 | === How this tally should be read === |
| 75 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: | 77 | The reception figure above is a count of self-reported submissions to PeptidePedia, not a score: this wiki publishes none, and the figure says how many people wrote in rather than how good anything is. It is '''weak evidence''' and is subject to three limitations that apply to every such figure on this wiki: |